Facilitates, Supports, and Aims to Expand the Conduct of Clinical Trials at Partners HealthCare Institutions
Brigham Takes on Leadership Role in COVID-19 Vaccine Trials Manufactured by Moderna, Inc., of Cambridge, Mass.
“This is the first phase 3 trial that will test the effectiveness of a vaccine against COVID-19, and we’ve been working diligently across industry, academia and government to pave a path for launching this trial rapidly and safely,” said Baden. “Our goal has been to not only launch this important trial, but also to develop a rapid, high-quality process for vaccine trials that are to come.”
Remdesivir at Forefront of Battle Against COVID-19
Brigham and Women’s Hospital became one of multiple sites for two open-label, randomized, phase 3 clinical trials to evaluate the safety and efficacy of remdesivir among hospitalized adults with COVID-19. BWH trial led by Francisco Marty, MD, of the Brigham’s Division of Infectious Diseases.
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
An upcoming clinical trial at Massachusetts General Hospital and two other Massachusetts hospitals will assess the efficacy of the drug favipiravir in treating patients with COVID-19.
Massachusetts Eye and Ear and Massachusetts General Hospital Advancing Novel Experimental Gene-based COVID-19 Vaccine, AAVCOVID
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV-2, the virus that causes COVID-19.
Quick Links
- Research Management
- Innovation
- Human Research Committee/IRB
- Research Compliance
- Human Research Quality Improvement
- Office of the General Council (OGC)
- Office for Interactions with Industry (OII)
- Materials & Equipment Management
- BWH Center for Clinical Investigation
- MGH Division of Clinical Research
- MGH Translational Research Center
- Partners eCare Research Core
- Research Patient Data Registry
- Partners Biobank